Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Chemokines in the Development and Progression of Alzheimer’s Disease
Jakub Wojcieszak, K Kuçzyńska, Jolanta B. Zawilska
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 9, pp. 1929-1951
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Infiltrating CD8+ T cells exacerbate Alzheimer’s disease pathology in a 3D human neuroimmune axis model
Mehdi Jorfi, Joseph Park, Clare K. Hall, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 9, pp. 1489-1504
Open Access | Times Cited: 96
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
Felicia Liana Andronie-Cioară, Adriana Ioana Ardelean, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1869-1869
Open Access | Times Cited: 89
Obesity-induced inflammation: connecting the periphery to the brain
Ophélia Le Thuc, Cristina García‐Cáceres
Nature Metabolism (2024) Vol. 6, Iss. 7, pp. 1237-1252
Closed Access | Times Cited: 22
A study to determine the effect of nano-selenium and thymoquinone on the Nrf2 gene expression in Alzheimer’s disease
Doha El‐Sayed Ellakwa, Laila Ahmed Rashed, Ola Ali, et al.
Future Science OA (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches
Haiyun Chen, Yuhan Zeng, Dan Wang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1478-1478
Open Access | Times Cited: 14
Adaptive immune changes associate with clinical progression of Alzheimer’s disease
Lynn van Olst, Alwin Kamermans, Sem Halters, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Decoding the role of the CCL2/CCR2 axis in Alzheimer’s disease and innovating therapeutic approaches: Keeping All options open
Reyhaneh Arfaei, Narges Mikaeili, Fatemeh Daj, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112328-112328
Closed Access | Times Cited: 9
Sex Differences in the Inflammatory Profile in the Brain of Young and Aged Mice
Brianna Cyr, Juan Pablo de Rivero Vaccari
Cells (2023) Vol. 12, Iss. 10, pp. 1372-1372
Open Access | Times Cited: 17
Tremendous Fidelity of Vitamin D3 in Age-related Neurological Disorders
Manjari Skv, Sharon Mariam Abraham, Omalur Eshwari, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 7211-7238
Closed Access | Times Cited: 7
IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions
Anton Shkundin, Angelos Halaris
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 488-488
Open Access | Times Cited: 7
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease
Xuemei Zeng, Tara K Lafferty, Anuradha Sehrawat, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer’s disease
Asmaa Badr, Kylene P. Daily, Mostafa Eltobgy, et al.
Brain Behavior and Immunity (2024) Vol. 119, pp. 919-944
Open Access | Times Cited: 4
Functionalized curcumin/ginsenoside Rb1 dual-loaded liposomes: Targeting the blood-brain barrier and improving pathological features associated in APP/PS-1 mice
De-kang Yan, Xiuwu Qu, Muhan Chen, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104633-104633
Closed Access | Times Cited: 10
Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease
Miriam Bettinetti‐Luque, Laura Trujillo‐Estrada, Eduardo García‐Fuentes, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 6, pp. 840-878
Open Access | Times Cited: 10
Blockage of CCL3 with neutralizing antibody reduces neuroinflammation and reverses Alzheimer disease phenotypes
Chao Wei, Jing Liu, Bing Wu, et al.
Brain Behavior and Immunity (2025)
Closed Access
Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy
Ladan Gol Mohammad Pour Afrakoti, Sanam Daneshpour Moghadam, Pezhman Hadinezhad
Journal of Alzheimer s Disease Reports (2025) Vol. 9
Open Access
The role of monocytes and macrophages in the progression of Alzheimer’s disease
Wenyi Nie, Yingbin Yue, Jingqing Hu
Frontiers in Immunology (2025) Vol. 16
Open Access
Spotlight on pro-inflammatory chemokines: regulators of cellular communication in cognitive impairment
Chenxu Wang, Jia‐Yi Wang, Zhichao Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
T Cells Trafficking into the Brain in Aging and Alzheimer’s Disease
Yue‐Zhang Ma, Jia‐Xin Cao, Yi-Shu Zhang, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 3
Targeting leptin/CCL3-CCL4 axes in NAFLD/MAFLD: a novel role for BPF in counteracting thalamic inflammation and white matter degeneration
Antonio Cardamone, Anna Rita Coppoletta, Roberta Macrì, et al.
Pharmacological Research (2024) Vol. 209, pp. 107417-107417
Open Access | Times Cited: 3
Involvement of inflammasomes in the pathogenesis of Alzheimer's disease
Narimene Beder, Mourad Belkhelfa, Hakim Leklou
Journal of Alzheimer s Disease (2024) Vol. 102, Iss. 1, pp. 11-29
Closed Access | Times Cited: 3
Investigating interleukin-8 in Alzheimer's disease: A comprehensive review
Delia Righi, Carlo Manco, Matteo Pardini, et al.
Journal of Alzheimer s Disease (2024)
Closed Access | Times Cited: 3
Role of chemokines in aging and age-related diseases
Jitendra Kumar Chaudhary, Ajay Kumar Danga, A. Leela Kumari, et al.
Mechanisms of Ageing and Development (2024), pp. 112009-112009
Closed Access | Times Cited: 3
Chemokines in patients with Alzheimer's disease: A meta-analysis
Hecheng Wang, Yu Zong, Lei Zhu, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 8
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
Joke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top